医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Promega Opens New Shanghai Facility

2012年11月15日 AM02:25
このエントリーをはてなブックマークに追加

Smart Multimedia Gallery

 

Promega celebrates the grand opening of a new facility for its China operations that includes molecular biology reagent production, research, development and cGMP manufacturing capabilities for molecular diagnostics products for the Chinese market. (Photo: Business Wire)Promega celebrates the grand opening of a new facility for its China operations that includes molecular biology reagent production, research, development and cGMP manufacturing capabilities for molecular diagnostics products for the Chinese market. (Photo: Business Wire)

View and Share Photo

Close Window


MADISON, Wis.

Promega Corporation celebrates the opening of a new facility for its China operations. The new site for Shanghai Promega Biological Products, Ltd. both replaces an existing molecular biology reagent production site and it provides additional research, development and cGMP manufacturing capabilities for molecular diagnostics products for the Chinese market.

Promega celebrates the grand opening of a new facility for its China operations that includes molecu ...

Promega celebrates the grand opening of a new facility for its China operations that includes molecular biology reagent production, research, development and cGMP manufacturing capabilities for molecular diagnostics products for the Chinese market. (Photo: Business Wire)

Since its purchase in June of this year, the building has been equipped for the manufacture of molecular biology and molecular diagnostic reagents. Under the leadership of General Manager Tom Duan, a team of 40 scientists, technicians and administrators will begin operations in the new facility in the next few weeks.

“China is an integral part of Promega’s manufacturing and business operations. In 1985, Promega and two Chinese partners established Sino-American Biotechnology Corporation (SABC), the first China-US biotech joint venture in China,” says Promega CEO Bill Linton. “This recent investment in the new Shanghai cGMP manufacturing facility represents Promega’s continued commitment to life science in China.” Among its 15 global branches, Promega also has a sales and marketing branch in Beijing.

The new facility, called Shanghai Promega Life Science Center, is one of five Promega manufacturing sites worldwide. Together these facilities manufacture biological and chemical reagents and instruments used in both life science research and molecular diagnostics. Promega products are manufactured under certified quality systems that meet the requirement of ISO 9001 or ISO 13485, depending on product intended use.

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 2,500 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 15 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20121114006409/en/

CONTACT

Promega Corporation
Penny Patterson, (608) 274-4330
Sr.
Director, Communications
penny.patterson@promega.com

同じカテゴリーの記事 

  • EMS Kegel Trainer BODYDOCTOR Opens New Era of Health Care Solutions in Global Femcare Market
  • EMSケーゲルトレーナー BODYDOCTOR、Femcareのグローバル市場でK-HEALTH CAREに注目が集まる
  • InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
  • METIS第3相臨床試験で主要評価項目を達成、非小細胞肺がんからの脳転移患者における頭蓋内進行までの期間を統計学的に有意に延長
  • Poxel to Report Its 2023 Annual Results by the End of April 2024